GLP-1 / Ozempic
US$ 22.91
glp 1 through ro GLP-1 medications are not just for weight loss β they are the most important drug class of our lifetime. π« A 2025 meta-analysis of 99,599 patients confirmed: β 20% reduction in major Real-World Evidence for GLP-1 Receptor
Description
To learn more, schedule a consultation today
doi: 10.1016/j.diabres.2015.12.003
Hepatic steatosis, a further component of the metabolic syndrome, is known to be more common in patients with IBD 110 and GLP-1RAs have previously been shown to be effective for reducing liver fat content, 111 and this represents another potential benefit to GLP-1RA therapy
The combined effect of slowed digestion, reduced appetite, and increased satiety from GLP-1 and protein can significantly support weight loss efforts
No approved single compound currently achieves all of that simultaneously
